Skip to content

Press Releases and Events

PRESS RELEASES AND EVENTS

Archived Events

There are currently no events to display.

Press Releases

Date Title and Summary View
Toggle Summary Intra-Cellular Therapies to Present at Upcoming Scientific Conferences View HTML
Toggle Summary Intra-Cellular Therapies Presents New Data from the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 167th Annual Meeting of the American Psychiatric Association View HTML
Toggle Summary Intra-Cellular Therapies Reports First Quarter 2014 Financial Results View HTML
Toggle Summary Intra-Cellular Therapies to Present at the Deutsche Bank 39th Annual Health Care Conference View HTML
Toggle Summary Intra-Cellular Therapies Announces Multiple Presentations on ITI-007 at the 4th Biennial Schizophrenia International Research Society (SIRS) Conference View HTML
Toggle Summary Intra-Cellular Therapies Announces Upcoming Presentations at the 4th Biennial Schizophrenia International Research Society Conference View HTML
Toggle Summary Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2013 Financial Results
– Conference Call and Webcast Today, March 25, at 4:30 p.m. ET –
View HTML
Toggle Summary Intra-Cellular Therapies to Announce 2013 Fourth Quarter And Full Year Financial Results and to Host Conference Call on Tuesday, March 25, at 4:30 pm Eastern Time View HTML
Toggle Summary Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations View HTML
Toggle Summary Intra-Cellular Therapies Announces Initiation of Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients with Dementia, Including Alzheimer's Disease View HTML
Toggle Summary Intra-Cellular Therapies to Present at the Cowen and Company 34th Annual Healthcare Conference View HTML
Toggle Summary Intra-Cellular Therapies to Present at Two Upcoming Healthcare Conferences View HTML
Toggle Summary Intra-Cellular Therapies Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares. View HTML
Toggle Summary Intra-Cellular Therapies Announces Pricing of Public Offering of Common Stock; To Begin Trading on NASDAQ Global Select Market under "ITCI" View HTML
Toggle Summary Intra-Cellular Therapies Cleared for Quotation on OTCQB.
Intra-Cellular Therapies, Inc. ("ITI"), a biopharmaceutical company focused on the development of therapeutics for CNS disorders, announced that its common stock has been approved for quotation on the OTC Markets - OTCQB tier (OTCQB) under the symbol "ITCI", and is expected to begin trading on December 20, 2013.
View HTML